Price trend, clinical benefit and within-class competition of drugs for metastatic Non-small cell lung cancer in China: a retrospective cohort study.
- DOI
- 10.1016/j.lanwpc.2026.101915
- Published
- 2026 Jul
- Container
- The Lancet regional health. Western Pacific
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.lanwpc.2026.101915,
title = {Price trend, clinical benefit and within-class competition of drugs for metastatic Non-small cell lung cancer in China: a retrospective cohort study.},
author = {Du X and Luo X and Zhang H and Shen T and Wang X and Guo Q and Lv X and Zhao X and Pu Y and Yang Y and Huang L and Zhang Y},
year = {2026},
journal = {The Lancet regional health. Western Pacific},
doi = {10.1016/j.lanwpc.2026.101915},
url = {https://doi.org/10.1016/j.lanwpc.2026.101915}
}RIS
TY - JOUR TI - Price trend, clinical benefit and within-class competition of drugs for metastatic Non-small cell lung cancer in China: a retrospective cohort study. AU - Du X AU - Luo X AU - Zhang H AU - Shen T AU - Wang X AU - Guo Q AU - Lv X AU - Zhao X AU - Pu Y AU - Yang Y AU - Huang L AU - Zhang Y PY - 2026 JO - The Lancet regional health. Western Pacific DO - 10.1016/j.lanwpc.2026.101915 UR - https://doi.org/10.1016/j.lanwpc.2026.101915 ER -
APA
X, D., X, L., H, Z., T, S., X, W., Q, G., X, L., X, Z., Y, P., Y, Y., L, H., & Y, Z. (2026). Price trend, clinical benefit and within-class competition of drugs for metastatic Non-small cell lung cancer in China: a retrospective cohort study.. The Lancet regional health. Western Pacific. https://doi.org/10.1016/j.lanwpc.2026.101915
Source records
- pubmed · retrieved 2026-09-25T14:54:28.419Z